Gestational diabetes mellitus modulates neonatal high-density lipoprotein composition and its functional heterogeneity

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1841, Issue 11, 2014, Pages 1619-1627

  Sreckovic, Ivana ^a   Birner Gruenberger, Ruth ^a,b,c   Besenboeck, Carolin ^a   Miljkovic, Milica ^d   Stojakovic, Tatjana ^a   Scharnagl, Hubert ^a   Marsche, Gunther ^a   Lang, Uwe ^a   Kotur Stevuljevic, Jelena ^d   Jelic Ivanovic, Zorana ^d   Desoye, Gernot ^a   Wadsack, Christian ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b AUSTRIAN CENTRE OF INDUSTRIAL BIOTECHNOLOGY   (Austria)

^c Omics Center Graz   (Austria)

^d UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Anti oxidative property; GDM; Neonatal HDL

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN M; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; FEMALE; GEL ELECTROPHORESIS; HUMAN; HUMAN TISSUE; INNATE IMMUNITY; LIPID COMPOSITION; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; NEWBORN; PREGNANCY DIABETES MELLITUS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEOMICS; TROPHOBLAST;

EID: 84907720790     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.07.021     Document Type: Article

References (43)

1. E.A. Ryan Diagnosing gestational diabetes Diabetologia 54 2011 480 486
2. H. Merzouk, S. Madani, N. Korso, M. Bouchenak, J. Prost, and J. Belleville Maternal and fetal serum lipid and lipoprotein concentrations and compositions in type 1 diabetic pregnancy: relationship with maternal glycemic control J. Lab. Clin. Med. 136 2000 441 448
3. D.J. Barker Fetal origins of coronary heart disease BMJ 311 1995 171 174
4. C.R. Gale, B. Jiang, S.M. Robinson, K.M. Godfrey, C.M. Law, and C.N. Martyn Maternal diet during pregnancy and carotid intima-media thickness in children Arterioscler. Thromb. Vasc. Biol. 26 2006 1877 1882
5. A. van der Graaf, M.N. Vissers, D. Gaudet, D. Brisson, S. Sivapalaratnam, T.J. Roseboom, A.C. Jansen, J.J. Kastelein, and B.A. Hutten Dyslipidemia of mothers with familial hypercholesterolemia deteriorates lipids in adult offspring Arterioscler. Thromb. Vasc. Biol. 30 2010 2673 2677
6. W. Palinski, and C. Napoli The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis FASEB J. 16 2002 1348 1360
7. M.D. Kilby, R.H. Neary, M.I. Mackness, and P.N. Durrington Fetal and maternal lipoprotein metabolism in human pregnancy complicated by type I diabetes mellitus J. Clin. Endocrinol. Metab. 83 1998 1736 1741
8. D.A. Lawlor, A. Fraser, R.S. Lindsay, A. Ness, D. Dabelea, P. Catalano, G. Davey Smith, N. Sattar, and S.M. Nelson Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort Diabetologia 53 2010 89 97
9. J.A. Rowan, E.C. Rush, V. Obolonkin, M. Battin, T. Wouldes, and W.M. Hague Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age Diabetes Care 34 2011 2279 2284
10. J. Stefulj, U. Panzenboeck, T. Becker, B. Hirschmugl, C. Schweinzer, I. Lang, G. Marsche, A. Sadjak, U. Lang, G. Desoye, and C. Wadsack Human endothelial cells of the placental barrier efficiently deliver cholesterol to the fetal circulation via ABCA1 and ABCG1 Circ. Res. 104 2009 600 608
11. I. Sreckovic, R. Birner-Gruenberger, B. Obrist, T. Stojakovic, H. Scharnagl, M. Holzer, M. Scholler, S. Philipose, G. Marsche, U. Lang, G. Desoye, and C. Wadsack Distinct composition of human fetal HDL attenuates its anti-oxidative capacity Biochim. Biophys. Acta 1831 2013 737 746
12. M. Scholler, C. Wadsack, J. Metso, A.P. Chirackal Manavalan, I. Sreckovic, C. Schweinzer, U. Hiden, M. Jauhiainen, G. Desoye, and U. Panzenboeck Phospholipid transfer protein is differentially expressed in human arterial and venous placental endothelial cells and enhances cholesterol efflux to fetal HDL J. Clin. Endocrinol. Metab. 97 2012 2466 2474
13. G. Marsche, M.D. Saemann, A. Heinemann, and M. Holzer Inflammation alters HDL composition and function: implications for HDL-raising therapies Pharmacol. Ther. 137 2013 341 351
14. A. Chait, C.Y. Han, J.F. Oram, and J.W. Heinecke Thematic review series: the immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease? J. Lipid Res. 46 2005 389 403
15. C. Morgantini, A. Natali, B. Boldrini, S. Imaizumi, M. Navab, A.M. Fogelman, E. Ferrannini, and S.T. Reddy Anti-inflammatory and antioxidant properties of HDLs are impaired in type 2 diabetes Diabetes 60 2011 2617 2623
16. American College of Obstetricians and Gynecologists Committee on Practice Bulletins - Obstetrics, ACOG Practice Bulletin Clinical management guidelines for obstetrician-gynecologists. Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994). Gestational diabetes Obstet. Gynecol. 98 2001 525 538
17. J.S. Cohn, R. Batal, M. Tremblay, H. Jacques, L. Veilleux, C. Rodriguez, O. Mamer, and J. Davignon Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism J. Lipid Res. 44 2003 1976 1983
18. O. Erel A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation Clin. Biochem. 37 2004 277 285
19. A. Blaschitz, U. Weiss, G. Dohr, and G. Desoye Antibody reaction patterns in first trimester placenta: implications for trophoblast isolation and purity screening Placenta 21 2000 733 741
20. I. Lang, A. Schweizer, U. Hiden, N. Ghaffari-Tabrizi, G. Hagendorfer, M. Bilban, M.A. Pabst, E.T. Korgun, G. Dohr, and G. Desoye Human fetal placental endothelial cells have a mature arterial and a juvenile venous phenotype with adipogenic and osteogenic differentiation potential Differentiation 76 2008 1031 1043
21. M. Szpakowski, M. Nowak, P. Oszukowski, A. Wieczorek, and A. Skotnicka C-reactive protein in normal pregnancy Ginekol. Pol. 67 1996 17 20
22. H. Nagasaka, H. Chiba, H. Kikuta, H. Akita, Y. Takahashi, H. Yanai, S.P. Hui, H. Fuda, H. Fujiwara, and K. Kobayashi Unique character and metabolism of high density lipoprotein (HDL) in fetus Atherosclerosis 161 2002 215 223
23. W.S. Davidson, R.A. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, and A. Kontush Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function Arterioscler. Thromb. Vasc. Biol. 29 2009 870 876
24. B. Shao Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL Biochim. Biophys. Acta 1821 2012 490 501
25. F. Altruda, V. Poli, G. Restagno, and L. Silengo Structure of the human hemopexin gene and evidence for intron-mediated evolution J. Mol. Evol. 27 1988 102 108
26. W.M. Old, K. Meyer-Arendt, L. Aveline-Wolf, K.G. Pierce, A. Mendoza, J.R. Sevinsky, K.A. Resing, and N.G. Ahn Comparison of label-free methods for quantifying human proteins by shotgun proteomics Mol. Cell. Proteomics 4 2005 1487 1502
27. J.S. Gilbert, C.T. Banek, S.A. Babcock, and H.C. Dreyer Diabetes in early pregnancy: getting to the heart of the matter Diabetes 62 2013 27 28
28. L.S. Fetita, E. Sobngwi, P. Serradas, F. Calvo, and J.F. Gautier Consequences of fetal exposure to maternal diabetes in offspring J. Clin. Endocrinol. Metab. 91 2006 3718 3724
29. A. Yessoufou, and K. Moutairou Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of "metabolic memory" Exp. Diabetes Res. 2011 2011 218598
30. E. Herrera, E. Amusquivar, I. Lopez-Soldado, and H. Ortega Maternal lipid metabolism and placental lipid transfer Horm. Res. 65 Suppl. 3 2006 59 64
31. E. Dube, M. Ethier-Chiasson, and J. Lafond Modulation of cholesterol transport by insulin-treated gestational diabetes mellitus in human full-term placenta Biol. Reprod. 88 2013 16
32. V.G. Cabana, J.R. Lukens, K.S. Rice, T.J. Hawkins, and G.S. Getz HDL content and composition in acute phase response in three species: triglyceride enrichment of HDL a factor in its decrease J. Lipid Res. 37 1996 2662 2674
33. H.B. G, V.S. Rao, and V.V. Kakkar Friend turns foe: transformation of anti-inflammatory HDL to proinflammatory HDL during acute-phase response Cholesterol 2011 274629 (2011)
34. L.C. Hudgins, T.S. Parker, D.M. Levine, B.R. Gordon, S.D. Saal, X.C. Jiang, C.E. Seidman, J.D. Tremaroli, J. Lai, and A.L. Rubin A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers J. Lipid Res. 44 2003 1489 1498
35. R.L. Kitchens, P.A. Thompson, R.S. Munford, and G.E. O'Keefe Acute inflammation and infection maintain circulating phospholipid levels and enhance lipopolysaccharide binding to plasma lipoproteins J. Lipid Res. 44 2003 2339 2348
36. M. Augsten, H. Hackl, B. Ebner, A. Chemelli, O. Glatter, G. Marsche, U. Lang, G. Desoye, and C. Wadsack Fetal HDL/apoE: a novel regulator of gene expression in human placental endothelial cells Physiol. Genomics 43 2011 1255 1262
37. S. Horkko, D.A. Bird, E. Miller, H. Itabe, N. Leitinger, G. Subbanagounder, J.A. Berliner, P. Friedman, E.A. Dennis, L.K. Curtiss, W. Palinski, and J.L. Witztum Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins J. Clin. Invest. 103 1999 117 128
38. O. Grissa, J.M. Ategbo, A. Yessoufou, Z. Tabka, A. Miled, M. Jerbi, K.L. Dramane, K. Moutairou, J. Prost, A. Hichami, and N.A. Khan Antioxidant status and circulating lipids are altered in human gestational diabetes and macrosomia Transl. Res. 150 2007 164 171
39. D. Farbstein, and A.P. Levy HDL dysfunction in diabetes: causes and possible treatments Expert. Rev. Cardiovasc. Ther. 10 2012 353 361
40. A.V. Khera, M. Cuchel, M. de la Llera-Moya, A. Rodrigues, M.F. Burke, K. Jafri, B.C. French, J.A. Phillips, M.L. Mucksavage, R.L. Wilensky, E.R. Mohler, G.H. Rothblat, and D.J. Rader Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N. Engl. J. Med. 364 2011 127 135
41. C. Christoffersen, H. Obinata, S.B. Kumaraswamy, S. Galvani, J. Ahnstrom, M. Sevvana, C. Egerer-Sieber, Y.A. Muller, T. Hla, L.B. Nielsen, and B. Dahlback Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M Proc. Natl. Acad. Sci. U. S. A. 108 2011 9613 9618
42. K.M. Argraves, P.J. Gazzolo, E.M. Groh, B.A. Wilkerson, B.S. Matsuura, W.O. Twal, S.M. Hammad, and W.S. Argraves High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function J. Biol. Chem. 283 2008 25074 25081
43. A. Muscari, C. Bozzoli, G.M. Puddu, Z. Sangiorgi, A. Dormi, C. Rovinetti, G.C. Descovich, and P. Puddu Association of serum C3 levels with the risk of myocardial infarction Am. J. Med. 98 1995 357 364